Results 251 to 260 of about 20,306,851 (378)

Structural insights into functional properties of the oxidized form of cytochrome c oxidase. [PDF]

open access: yesNat Commun, 2023
Ishigami I   +13 more
europepmc   +1 more source

Solanidine‐derived CYP2D6 phenotyping elucidates phenoconversion in multimedicated geriatric patients

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Phenoconversion, a genotype‐phenotype mismatch, challenges a successful implementation of personalized medicine. The aim of this study was to detect and determine phenoconversion using the solanidine metabolites 3,4‐seco‐solanidine‐3,4‐dioic acid (SSDA) and 4‐OH‐solanidine as diet‐derived cytochrome P450 2D6 (CYP2D6) biomarkers in a ...
Jens Andreas Sarömba   +9 more
wiley   +1 more source

Integrative Genomic and in Silico Analysis Reveals Mitochondrially Encoded Cytochrome C Oxidase III (MT-CO3) Overexpression and Potential Neem-Derived Inhibitors in Breast Cancer. [PDF]

open access: yesGenes (Basel)
Agboola OE   +10 more
europepmc   +1 more source

Mitochondrial Protein SLIRP Affects Biosynthesis of Cytochrome c Oxidase Subunits in HEK293T Cells. [PDF]

open access: yesInt J Mol Sci, 2023
Baleva MV   +5 more
europepmc   +1 more source

Transport of cytochrome c heme lyase [PDF]

open access: yes, 1983
Hennig, Bernd   +3 more
core   +1 more source

Investigation of a broad‐spectrum micronutrient formulation as a possible precipitant of pharmacokinetic micronutrient–drug interactions

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Daily broad‐spectrum micronutrients are being used by the general public and formulations are receiving research interest in mental health settings. Despite concerns about combining medicines and broad‐spectrum micronutrients in mental health care, there have not been any formal evaluations of potential interactions.
Bess M. Kew   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy